Skip to content

CMV antiviral may reduce inflammation and improve immune function in people with HIV

Dr Sara Gianelle Weibel talking at a media briefing at CROI 2025.

HIV testing requirements must be simplified for injectable PrEP to have a future

A person having a blood test.

Simpler PrEP services – fewer check-ups, online care – work as well as the standard approach

A person holding a small blue tablet and a glass of water.

Beyond cholesterol: statins may protect heart health in people with HIV through multiple mechanisms

Professor Steven Grinspoon at a media briefing at CROI 2025, talking into a microphone.

Coronary artery disease uncommon in people with HIV in Uganda

Dr Mark Siedner presenting at CROI 2025. He is standing behind a lectern talking into a microphone.

Why aren’t more people with HIV accessing doxyPEP?

A person in a grey tshirt holding a white pill.

HIV acquisition in women with good adherence to TAF/FTC PrEP is rare

A bottle of blue pills is spilling out onto a table.

New long-acting HIV drugs show promising early results

Dr Luise Rogg (who presented the VH-184 study) at a media briefing at CROI 2025. Luise is talking into a microphone.

Broadly neutralising antibody N6LS could be part of long-acting HIV treatment

Dr Babafemi Taiwo talking into a microphone at a media briefing at CROI 2025.